Moderna said on Friday that the U.S. FDA paused a late-stage trial of its experimental norovirus vaccine after a case of a ...

The 71-year-old nephew of the assassinated president John F. Kennedy is expected to win approval as Republicans yet again ...

Fintel reports that on February 18, 2025, Barclays downgraded their outlook for Moderna (NasdaqGS:MRNA) from Overweight to Equal-Weight. Analyst Price Forecast Suggests 78.68% Upside As of February 18 ...

While still robust, CSL half-year results last Weds revealed impact of an “alarming” fall off in 'flu vax rates, especially ...

Fintel reports that on February 18, 2025, Deutsche Bank downgraded their outlook for Merck (NYSE:MRK) from Buy to Hold.

Here’s what you need to know.

China started construction on 94.5 gigawatts of coal-fired power in 2024, the highest volume of new builds since 2015, ...

Senior U.S. and Russian officials agreed yesterday not only to work together on ending the war in Ukraine, but also to ...

CSL has received approval from the EC for Andembry (garadacimab) to prevent recurrent attacks of HAE in patients aged 12 ...

Zebra Technologies (NASDAQ:ZBRA – Free Report) had its price objective decreased by Morgan Stanley from $427.00 to $390.00 in ...

Vanguard hasn’t been immune to investors ... as it believes there is long-term potential with its vaccine development. While the strategy is overweight biotech, its limited exposure to ...